CYP11A1 expression in bone is associated with aromatase inhibitor-related bone loss.

MLA

Rodríguez-Sanz, M., et al. “CYP11A1 Expression in Bone Is Associated with Aromatase Inhibitor-Related Bone Loss.” Journal of Molecular Endocrinology, vol. 55, no. 1, Aug. 2015, pp. 69–79. EBSCOhost, https://doi.org/10.1530/JME-15-0079.

APA

Rodríguez-Sanz, M., García-Giralt, N., Prieto-Alhambra, D., Servitja, S., Balcells, S., Pecorelli, R., Díez-Pérez, A., Grinberg, D., Tusquets, I., & Nogués, X. (2015). CYP11A1 expression in bone is associated with aromatase inhibitor-related bone loss. Journal of Molecular Endocrinology, 55(1), 69–79. https://doi.org/10.1530/JME-15-0079

Chicago

Rodríguez-Sanz, M, N García-Giralt, D Prieto-Alhambra, S Servitja, S Balcells, R Pecorelli, A Díez-Pérez, D Grinberg, I Tusquets, and X Nogués. 2015. “CYP11A1 Expression in Bone Is Associated with Aromatase Inhibitor-Related Bone Loss.” Journal of Molecular Endocrinology 55 (1): 69–79. doi:10.1530/JME-15-0079.